| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/26/1999 | US5864015 Hodgkin's disease associated molecules |
| 01/26/1999 | US5864013 Materials for the production of nanometer structures and use thereof |
| 01/26/1999 | US5863905 2',5'-phosphorothioate/phosphodiester oligoadenylates and anti-viral uses thereof |
| 01/26/1999 | US5863893 Anticoagulants |
| 01/26/1999 | US5863891 Protein fragments joined by peptide bonds |
| 01/26/1999 | US5863796 Immunizing a mammal with specific polypeptide and collecting the antibody |
| 01/26/1999 | US5863784 Obtained by site-directed mutagenesis with recombinant beta-amylase gene coding 531 amino acids; substitutions were met181 with leu, ser291 with ala, ile293 with val, ser346 with pro, ser347 with pro, gln348, with asp, ala372 with ser |
| 01/26/1999 | US5863772 Discriminating animal and plant individuals on the basis of a difference in dna sequence, using dna oligonucleotide primer having a symmetrical base sequence, producing amplified dna fragments, separating by electrophoresis, silver staining |
| 01/26/1999 | US5863767 Keratinocyte growth factor fragment lacks the first 23 amino acid residues of the n-terminus of mature, full-length kgf; treatment of hyperproliferative disease of epidermis |
| 01/26/1999 | US5863757 An expression vector comprising polynucleotide having an open reading frame operably linked to a promoter and encoding a specific polypeptide |
| 01/26/1999 | US5863756 Utilize recombinant pace 4 and 4.1, mammalian endopeptidases that are specific for dibasic amino acid sites; therapeutic compositions and methods employing pace 4 or 4.1 or their inhibitors are also provided |
| 01/26/1999 | US5863755 Nucleic acid encoding novel receptor-type phosphotyrosine phosphatase-κ |
| 01/26/1999 | US5863727 An acceptor fluorophore efficiently absorbs energy emission of a linked donor xanthene fluorophore labelling a oligonucleotide primer; reagent for sequencing nucleic acids |
| 01/26/1999 | US5863724 Methods of screening for persistent hyperinsulinemic hypoglycemia of infancy |
| 01/26/1999 | US5863722 Method of sorting polynucleotides |
| 01/26/1999 | US5863528 Porcine cytokines |
| 01/26/1999 | CA1340343C Protected biotin derivatives |
| 01/26/1999 | CA1340329C Superoxide dismutasee |
| 01/26/1999 | CA1340328C Method for protein binding enzyme complementation assays |
| 01/21/1999 | WO1999002544A1 Compounds having energy transfer function and method for dna base sequencing by using the same |
| 01/21/1999 | WO1999002167A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 01/21/1999 | CA2265551A1 Compounds having energy transfer function and method for dna base sequencing by using the same |
| 01/20/1999 | EP0891393A1 Asymmetric benzoxanthene dyes |
| 01/20/1999 | EP0891374A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 01/20/1999 | EP0891373A1 Method and compounds for inhibition of ribonucleases |
| 01/20/1999 | EP0891372A1 Growth factor htter36 |
| 01/20/1999 | EP0891369A1 Process and device for isolating nucleic acids |
| 01/20/1999 | EP0891184A1 Method for solubilising hydrophylic materials (e.g. proteins) in a hydrophobic solvent |
| 01/20/1999 | EP0767657A4 Novel method of preparation of known and novel 2'-modified nucleosides by intramolecular nucleophilic displacement |
| 01/20/1999 | EP0675965A4 Polynucleotide immobilized support. |
| 01/19/1999 | US5861501 Capped synthetic RNA, analogs, and aptamers |
| 01/19/1999 | US5861493 Process for the synthesis of 2'-O-substituted pyrimidines |
| 01/19/1999 | US5861480 Capable of isolation from seeds of aralia or impatiens exhibit antifungal and antibacterial activity |
| 01/19/1999 | US5861378 Polypeptides having specified amino acid sequences; antiseptics, effective against grampositive and gramnegative bacteria |
| 01/19/1999 | US5861377 Antistasin type serine protease inhibitors |
| 01/19/1999 | US5861314 Genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (aav) material for genomes |
| 01/19/1999 | US5861309 Amino acid sequences encoding it, vectors for its expression in yeast, bacterial, and mammalian cells; research into the characterization of the pharmacology of individual human alpha 1 receptor subtypes |
| 01/19/1999 | US5861307 Liposomes embedded with dna; antitumor agents; apotosis |
| 01/19/1999 | US5861287 Distinguishing polynucleotides with 3'-terminal dideoxynucleotides with dna sequencing requiring electrophoresis |
| 01/19/1999 | US5861276 CDNAS encoding murine antibody against human plasma apolipoprotein B-100 |
| 01/19/1999 | US5861259 Immunoassays for human cyclin E |
| 01/19/1999 | US5861252 Method of analysis or assay for polynucleotides and analyzer or instrument for polynucleotides |
| 01/19/1999 | US5861250 Protecting nucleic acids and methods of analysis |
| 01/19/1999 | US5861242 Array of oligonucleotide probes immobilized on a solid support for analysis of a target sequence from a human immunodeficiency virus |
| 01/19/1999 | US5861171 Adeno-associated viral (AAV) liposomes and methods related thereto |
| 01/19/1999 | US5861157 An immunogenic fragment obtained from a bacterial protein capable of eliciting antibody response |
| 01/19/1999 | US5861156 Methods of delivering agents to target cells |
| 01/19/1999 | CA1340323C Rna catalyst for cleaving specific rna sequences |
| 01/19/1999 | CA1340322C Human papillomavirus type 41, its dna and the proteins encoded therefrom |
| 01/14/1999 | WO1999001579A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 01/14/1999 | WO1999001571A2 Compositions and methods for detecting vancomycin resistant enterococci by cycling probe reactions |
| 01/14/1999 | CA2294988A1 Compositions and methods for the delivery of oligonucleotides via the alimentary canal |
| 01/14/1999 | CA2294565A1 Compositions and methods for detecting vancomycin resistant enterococci by cycling probe reactions |
| 01/13/1999 | EP0890363A2 A device for nucleic acid sterilization |
| 01/13/1999 | EP0889959A1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease |
| 01/13/1999 | EP0889899A1 Mycoplasma arthritidis superantigen |
| 01/13/1999 | EP0889728A2 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 01/13/1999 | CN1205079A Transistor-based apparatus and method for molecular detection and field enhancement |
| 01/12/1999 | US5859346 Crucifer AFT proteins and uses thereof |
| 01/12/1999 | US5859336 Synthetic DNA sequence having enhanced activity in maize |
| 01/12/1999 | US5859259 Activated esters of 1-phenylpyrazolin-5-one for labeling amine-functionalized molecules |
| 01/12/1999 | US5859234 3'-diisopropylmethylphosphonamidityl-5'-dimethoxytrityl-n4 -isobutyryl-2'-o-methylcytidine monomer do not undergo transamination for efficient oligonucleotide and methylphosphonate oligomer synthesis |
| 01/12/1999 | US5859233 Synthons for synthesis of oligonucleotide N3-P5 phosphoramidates |
| 01/12/1999 | US5859232 Process for the synthesis of oligomeric phosphite, phosphodiester, phosphorothioate and phosphorodithioate compounds |
| 01/12/1999 | US5859231 Synthesizing an oligonucleotide comprsing an internucleotide h-phosphate diester linkage, reacting diester with bis/trimethylsilyl/acetamide or halogenating agent to form triester, boronating with amine borane; reacting with ammonia |
| 01/12/1999 | US5859229 For inhibition of gene expression of human cyclooxygenase 2 by binding to specific untranslated regions of messenger rna; treatment of premature labor, preeclampsia, endometriosis, rheumatoid arthritis |
| 01/12/1999 | US5859228 Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
| 01/12/1999 | US5859224 Base sequence of the coat protein gene of papaya leaf-distortion mosaic virus |
| 01/12/1999 | US5859223 Dna molecules coding for no more than three short consensus repeats including scr3 of long homologous repeat a of complement receptor 1; antiinflammatory agents; multiple sclerosis; parkinson's/alzheimer's disease |
| 01/12/1999 | US5859221 Hybrid dna, rna; nuclease resistant |
| 01/12/1999 | US5859219 Isolated nucleotide sequences used for detection of infection as primers for amplification and probes for hybridization; antiulcer agents; anticancer agents |
| 01/12/1999 | US5859208 Human basic fibroblast growth factor analog |
| 01/12/1999 | US5858988 Poly-substituted-phenyl-oligoribo nucleotides having enhanced stability and membrane permeability and methods of use |
| 01/12/1999 | US5858976 Inhibiting tumor cell growth by administering dna for gene expression of a polypeptide fragment of p53, which regulates cell growth, capable of binding to novel human mdm2, a cancer-causing gene product that normally sequesters p53 |
| 01/12/1999 | US5858963 Inducing xenograft tolerance and porcine cytokines therefor |
| 01/12/1999 | US5858780 Cisplatin resistant cell line |
| 01/12/1999 | US5858744 Gene transfer into stem cells |
| 01/12/1999 | US5858740 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 01/12/1999 | US5858731 Nucleotide sequences including nondegenerate and degenerate nucleotide bases which can be ligated together for longer molecules; for rapid and efficient synthesis of preselected sequences for dna sequencing, polymerase chain reaction |
| 01/12/1999 | US5858729 Preparation of glycosylated open reading frames 3 and 4 of protein associated with mystery swine disease, by co-infecting, culturing, harvesting eukaryotic cells with subgenomic dna fragments in viral vectors |
| 01/12/1999 | US5858727 Secretion of outer membrane proteins of gram-negative bacteria by means of gram-positive host organisms |
| 01/12/1999 | US5858674 Screening assays to identify agents that modulate cisplatin resistance |
| 01/12/1999 | US5858670 Screening randomly synthesized oligopeptide- or oligonucleotide-solid phase libraries with acceptor molecules (e.g. antibodies), isolating solid phase support/oligomer bound to molecule, sequencing oligomer |
| 01/12/1999 | US5858668 Homogeneous gene probe test using a receptor directed against the label |
| 01/12/1999 | US5858660 Parallel selex |
| 01/12/1999 | US5858658 Amplification of repetive sequences in both sample and added standard nucleic acids using complemtary primers, determining total amount of heterogenous, contaminant dna, for quality control of recombinant products |
| 01/12/1999 | US5858656 Indexing linkers |
| 01/12/1999 | US5858376 Introducing into cell isolated protein derived from herpes simplex virus |
| 01/12/1999 | CA2117903C Targeted cleavage of rna using eukaryotic ribonuclease and external guide sequence |
| 01/07/1999 | WO1999000521A1 Lyophilization of cultured human cells to preserve rna and dna |
| 01/07/1999 | WO1999000402A1 Purification of oligomers |
| 01/07/1999 | WO1999000401A1 3'-monophosphorylating oligonucleotides |
| 01/07/1999 | EP0889122A2 Inhibition of DNA Methyltransferase |
| 01/07/1999 | EP0889120A1 A micro-organism having reduced adaption to a particular environment |
| 01/07/1999 | EP0888456A2 Prostate specific antigen oligo-epitope peptide |
| 01/07/1999 | EP0888374A1 High affinity nucleic acid ligands of complement system proteins |
| 01/07/1999 | EP0888372A1 Oligonucleotide-anthracycline and oligonucleotide-anthracyclinone conjugates |
| 01/07/1999 | EP0888367A1 Isolated rna molecules which bind to arginine and uses thereof |
| 01/07/1999 | EP0888110A1 Composite gel microparticles as active principle carriers |
| 01/07/1999 | EP0525076B1 Recombinant bile salt activated lipases |